| Drug Name |
Tazarotene |
| Drug ID |
BADD_D02120 |
| Description |
Tazarotene, commonly marketed as Tazorac®, Avage®, and Zorac®, is member of the acetylenic class of retinoids. It is a prodrug that is found in topical formulations used in the treatment of various conditons, such as psoriasis, acne, and sun damaged skin (photodamage). |
| Indications and Usage |
Used to treat psoriasis, acne and sun damaged skin (photodamage). |
| Marketing Status |
approved; investigational |
| ATC Code |
D05AX05 |
| DrugBank ID |
DB00799
|
| KEGG ID |
D01132
|
| MeSH ID |
C086827
|
| PubChem ID |
5381
|
| TTD Drug ID |
D0BM5G
|
| NDC Product Code |
51672-1374; 68308-745; 16110-915; 51014-7755; 45802-442; 0023-0042; 60758-556; 68308-685; 17337-0064; 0713-0804; 17337-0065; 51552-1519; 71052-558; 16110-916; 0023-8335; 0713-0670; 48943-0028; 16110-833; 0187-2098; 51672-1373; 66039-836; 45802-436; 60758-561; 55679-114; 73309-058; 51862-295; 0713-0805; 16110-042; 48943-0027 |
| UNII |
81BDR9Y8PS
|
| Synonyms |
tazarotene | ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate | Tazorac | AGN 190168 | AGN-190168 |
